U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07082816) titled 'Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction' on July 17.
Brief Summary: This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
Study Start Date: Sept., 2025
Study Type: INTERVENTIONAL
Condition:
Ocular Hypertension
Open Angle Glaucoma
Intervention:
DRUG: Netarsudil 0.01%/latanoprost 0.005% ophthalmic solution
Investigational ophthalmic solution
DRUG: Netarsudil 0.02%/latanoprost 0.005% ophthalmic solution
Commercially available ophthalmic solution
Recruit...